The endothelium at the brink of calamity in storage disease: More than just overloaded with junk?

Cardiovascular Research

Volumn 89, Issue 2, 2011, Pages 258-259

  De Wit, Cor ^a  

^a Universitt zu Lbeck   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; CALMODULIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLOBOTRIAOSYLCERAMIDE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; TRANSCRIPTION FACTOR AP 1;

EDITORIAL; ENDOTHELIAL DYSFUNCTION; FABRY DISEASE; HUMAN; HYPERPOLARIZATION; NONHUMAN; POTASSIUM CHANNELOPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VASODILATATION;

ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FABRY DISEASE; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MEMBRANE POTENTIALS; MEMBRANE TRANSPORT MODULATORS; MICE; SIGNAL TRANSDUCTION; TRIHEXOSYLCERAMIDES; VASODILATION;

EID: 78751514607     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq386     Document Type: Editorial

References (15)

1. de Wit C, Griffith TM. Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. Pflugers Arch 2010;459:897-914.
2. Zarate YA, Hopkin RJ. Fabry's disease. Lancet 2008;372:1427-1435.
3. Park S, Kim JA, Joo KY, Choi S, Choi EN, Shin JA et al. Globotriaosylceramide leads to KCa3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease. Cardiovasc Res 2011;89:290-299.
4. Brakemeier S, Kersten A, Eichler I, Grgic I, Zakrzewicz A, Hopp H et al. Shear stress-induced up-regulation of the intermediate-conductance Ca2+-activated K+ channel in human endothelium. Cardiovasc Res 2003;60:488-496.
5. Shu L, Park JL, Byun J, Pennathur S, Kollmeyer J, Shayman JA. Decreased nitric oxide bioavailability in a mouse model of Fabry disease. J Am Soc Nephrol 2009;20: 1975-1985.
6. Si H, Heyken WT, Wö lfle SE, Tysiac M, Schubert R, Grgic I et al. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 2006;99:537-544.
7. Wö lfle SE, Schmidt VJ, Hoyer J, Köhler R, de Wit C. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo. Cardiovasc Res 2009; 82: 476-483.
8. Brähler S, Kaistha A, Schmidt VJ, Wö lfle SE, Busch C, Kaistha BP et al. Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation 2009;119:2323-2332.
9. Thurberg BL, Fallon JT, Mitchell R, Aretz T, Gordon RE, O'Callaghan MW. Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy. Circulation 2009;119:2561-2567.
10. Schaefer RM, Tylki-Szymanska A, Hilz MJ. Enzyme replacement therapy for Fabry disease: a systematic review of available evidence. Drugs 2009;69:2179-2205.
11. Krö tz F, Hellwig N, Burkle MA, Lehrer S, Riexinger T, Mannell H et al. A sulfaphenazole-sensitive EDHF opposes platelet-endothelium interactions in vitro and in the hamster microcirculation in vivo. Cardiovasc Res 2010; 85: 542-550.
12. Sankaranarayanan A, Raman G, Busch C, Schultz T, Zimin PI, Hoyer J et al. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 2009;75:281-295.
13. Dora KA, Gallagher NT, McNeish A, Garland CJ. Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circ Res 2008;102:1247-1255.
14. Milkau M, Kohler R, de Wit C. Crucial importance of the endothelial K+ channel SK3 and connexin40 in arteriolar dilations during skeletal muscle contraction. FASEB J 2010;24:3572-3579.
15. de Wit C. Different pathways with distinct properties conduct dilations in the microcirculation in vivo. Cardiovasc Res 2010;85:604-613.